News
New research on using weight loss drugs for treating alcohol use disorder
Some weight loss and diabetes drugs that use GLP-1s have been found to help people stop drinking. Channel 5's GM released a statement saying the station and its parent company require employees "to adhere to the highest ethical standards.
However, it is important to note that the study's cross-sectional design means these findings are correlational, not causal; the data do not show that these factors cause interest in GLP-1 use ...
The phase 2 ELAD study of Novo Nordisk's once-daily injectable GLP-1 agonist liraglutide in people with early-stage Alzheimer's has shown that the drug was able to reduce shrinking in the areas ...
GLP-1 drugs have helped ... on proper medication use, resistance training, and adequate protein intake. Body composition was measured at the start of the study, at three months, and again at ...
The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.
The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...
Study presented at DDW ... trial design to support drug development. The study titled, "A Genetic Risk Score Associated with Nausea Resulting from GLP-1 Agonist Treatment: A Post-Hoc Analysis ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...
Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered ... highest dose of the drug scored an A1C less ...
The use of GLP-1s among patients with type 2 diabetes appeared associated with significantly reduced risk for certain ...
Doug Long, VP, industry relations, IQVIA, discusses how soaring demand for GLP-1 therapies is driving reimbursement challenges, shifting distribution models, and expanding the drugs’ potential into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results